AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics (including Botox).
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics (including Botox).
$293.8B
Market Cap • 11/18/20242012
(12 years)
2012
(12 years ago)
NYSE
Listing Exchange
North Chicago
Headquarters • IllinoisS&P500 Participant
Index Composite • 2024Premium
...and much more!